Cargando…

Biannual versus annual mass azithromycin distribution and malaria seroepidemiology among preschool children in Niger: a sub-study of a cluster randomized trial

BACKGROUND: Biannual mass azithromycin administration to preschool children reduces all-cause mortality, but the mechanism for the effect is not understood. Azithromycin has activity against malaria parasites, and malaria is a leading cause of child mortality in the Sahel. The effect of biannual ver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oldenburg, Catherine E., Amza, Abdou, Cooley, Gretchen, Kadri, Boubacar, Nassirou, Beido, Arnold, Benjamin F., Rosenthal, Philip J., O’Brien, Kieran S., West, Sheila K., Bailey, Robin L., Porco, Travis C., Keenan, Jeremy D., Lietman, Thomas M., Martin, Diana L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889587/ https://www.ncbi.nlm.nih.gov/pubmed/31796025 http://dx.doi.org/10.1186/s12936-019-3033-2

Ejemplares similares

Effect of Biannual Mass Azithromycin Distributions to Preschool-Aged Children on Trachoma Prevalence in Niger: A Cluster Randomized Clinical Trial
por: Arzika, Ahmed M., et al.
Publicado: (2022)

Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR)
por: O’Brien, Kieran S., et al.
Publicado: (2021)

Effect of biannual azithromycin distribution on antibody responses to malaria, bacterial, and protozoan pathogens in Niger
por: Arzika, Ahmed M., et al.
Publicado: (2022)

Mass Azithromycin and Malaria Parasitemia in Niger: Results from a Community-Randomized Trial
por: O'Brien, Kieran S., et al.
Publicado: (2017)

Azithromycin Reduction to Reach Elimination of Trachoma (ARRET): study protocol for a cluster randomized trial of stopping mass azithromycin distribution for trachoma
por: Amza, Abdou, et al.
Publicado: (2021)

Does Mass Azithromycin Distribution Impact Child Growth and Nutrition in Niger? A Cluster-Randomized Trial
por: Amza, Abdou, et al.
Publicado: (2014)

Impact of Biannual Mass Azithromycin Treatment on Enteropathogen Carriage in Children <5 Years Old in Niger
por: Platts-Mills, James A, et al.
Publicado: (2022)

A Cluster-Randomized Controlled Trial Evaluating the Effects of Mass Azithromycin Treatment on Growth and Nutrition in Niger
por: Amza, Abdou, et al.
Publicado: (2013)

Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: A cluster-randomized, placebo-controlled trial
por: Arzika, Ahmed M., et al.
Publicado: (2019)

Optimal Seasonal Timing of Oral Azithromycin for Malaria
por: Gao, Daozhou, et al.
Publicado: (2014)

Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger
por: Kim, Jessica S., et al.
Publicado: (2019)

Biannual azithromycin distribution and child mortality among malnourished children: A subgroup analysis of the MORDOR cluster-randomized trial in Niger
por: O’Brien, Kieran S., et al.
Publicado: (2020)

Effect of Mass Azithromycin Distributions on Childhood Growth in Niger: A Cluster-Randomized Trial
por: Arzika, Ahmed M., et al.
Publicado: (2021)

Malaria Parasitemia and Nutritional Status during the Low Transmission Season in the Presence of Azithromycin Distribution among Preschool Children in Niger
por: Arzika, Ahmed M., et al.
Publicado: (2020)

Erratum to: Short-term forecasting of the prevalence of clinical trachoma: utility of including delayed recovery and tests for infection
por: Liu, Fengchen, et al.
Publicado: (2016)

Short-term forecasting of the prevalence of clinical trachoma: utility of including delayed recovery and tests for infection
por: Liu, Fengchen, et al.
Publicado: (2015)

Temporal Trends in Phenotypic Macrolide and Nonmacrolide Resistance for Streptococcus pneumoniae Nasopharyngeal Samples Up to 36 Months after Mass Azithromycin Administration in a Cluster-Randomized Trial in Niger
por: Hazel, Ashley, et al.
Publicado: (2023)

Community Risk Factors for Ocular Chlamydia Infection in Niger: Pre-Treatment Results from a Cluster-Randomized Trachoma Trial
por: Amza, Abdou, et al.
Publicado: (2012)

Biannual Treatment of Preschool Children with Single Dose Azithromycin to Reduce Mortality: Impact on Azithromycin Resistance in the MORDOR Trial in Tanzania
por: Bloch, Evan M., et al.
Publicado: (2020)

Gut Resistome of Preschool Children After Prolonged Mass Azithromycin Distribution: A Cluster-randomized Trial
por: Arzika, Ahmed M, et al.
Publicado: (2021)

Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial
por: Keenan, Jeremy D, et al.
Publicado: (2020)

Impact of Biannual Azithromycin on Anemia in Preschool Children in Kilosa District, Tanzania: A Cluster-Randomized Clinical Trial
por: Bloch, Evan M., et al.
Publicado: (2020)

Application of smartphone cameras for detecting clinically active trachoma
por: Bhosai, Satasuk Joy, et al.
Publicado: (2012)

The Easiest Children to Reach Are Most Likely to Be Infected with Ocular Chlamydia trachomatis in Trachoma Endemic Areas of Niger
por: Amza, Abdou, et al.
Publicado: (2013)

Short-term Forecasting of the Prevalence of Trachoma: Expert Opinion, Statistical Regression, versus Transmission Models
por: Liu, Fengchen, et al.
Publicado: (2015)

Correction: Short-term Forecasting of the Prevalence of Trachoma: Expert Opinion, Statistical Regression, versus Transmission Models
por: Liu, Fengchen, et al.
Publicado: (2015)

Mass Azithromycin Distribution to Prevent Childhood Mortality: A Pooled Analysis of Cluster-Randomized Trials
por: Oldenburg, Catherine E., et al.
Publicado: (2019)

Safety of azithromycin in infants under six months of age in Niger: A community randomized trial
por: Oldenburg, Catherine E., et al.
Publicado: (2018)

Reliability of Trachoma Clinical Grading—Assessing Grading of Marginal Cases
por: Rahman, Salman A., et al.
Publicado: (2014)

Selection of Macrolide and Non-Macrolide Resistance with Mass Azithromycin Distribution: A Community-Randomized Trial
por: Doan, Thuy, et al.
Publicado: (2020)

Effects of Biannual Azithromycin Mass Drug Administration on Malaria in Malawian Children: A Cluster-Randomized Trial
por: Hart, John D., et al.
Publicado: (2020)

Stopping azithromycin mass drug administration for trachoma: A systematic review
por: Mahmud, Hamidah, et al.
Publicado: (2021)

Evaluating the impact of biannual school-based and community-wide treatment on urogenital schistosomiasis in Niger
por: Phillips, Anna E., et al.
Publicado: (2020)

Causes of death after biannual azithromycin treatment: A community-level randomized clinical trial
por: Bloch, Evan M., et al.
Publicado: (2021)

Adverse Events and Clinic Visits following a Single Dose of Oral Azithromycin among Preschool Children: A Randomized Placebo-Controlled Trial
por: Sié, Ali, et al.
Publicado: (2021)

MORDOR II: Persistence of Benefit of Azithromycin for Childhood Mortality
por: Keenan, Jeremy D., et al.
Publicado: (2019)

Linear growth in preschool children treated with mass azithromycin distributions for trachoma: A cluster-randomized trial
por: Keenan, Jeremy D., et al.
Publicado: (2019)

Comparison of door-to-door and fixed-point delivery of azithromycin distribution for child survival in Niger: A cluster-randomized trial
por: Arzika, Ahmed M., et al.
Publicado: (2023)

The impact on malaria of biannual treatment with azithromycin in children age less than 5 years: a prospective study
por: Bloch, Evan M., et al.
Publicado: (2019)

The distribution of the prevalence of ocular chlamydial infection in communities where trachoma is disappearing
por: Lietman, Thomas M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9s7sfv976u0ueenleg0slkh4ga